J. Salles et al., SUSTAINED INCREASE IN RAT MYOCARDIAL ALPHA(1A)-ADRENOCEPTORS INDUCED BY 6-HYDROXYDOPAMINE TREATMENT INVOLVES A DECELERATED RECEPTOR TURNOVER, Naunyn-Schmiedeberg's archives of pharmacology, 353(4), 1996, pp. 408-416
The biochemical mechanisms involved in the alpha(1)-adrenoceptor up-re
gulation and possible changes in subtypes of adrenoceptors in the rat
heart after chemical denervation were investigated. The effects of acu
te 6-hydroxydopamine treatment (two increasing doses 24 h apart) on th
e pseudo-steady state densities and turnover rates of alpha(1)-adrenoc
eptors were studied in ventricular myocardium of the rat. We have asse
ssed the repopulation kinetics of [H-3]prazosin binding sites after ir
reversible inactivation of alpha(1)-adrenoceptors induced by a single
dose of phenoxybenzamine (1 mg/kg i.p.) in rats acutely treated either
with 6-hydroxydopamine or with vehicle (control animals). Seven days
after the last administration of 6-hydroxydopamine an enhanced density
of [H-3]prazosin binding sites (B-max 58.7 +/- 3.6 fmol/mg protein ve
hicle-treated rats versus 82.6 +/- 5.3 fmol/mg protein 6-hydroxydopami
ne-treated rats) was observed. This was not accompanied by changes in
the dissociation constant value. Furthermore, the proportion of high a
ffinity sites for WB-4101 was altered (21 +/- 2% versus 72 +/- 3% for
animals treated with vehicle and 6-hydroxydopamine, respectively). In
rat myocardium, alpha(1)-adrenoceptor turnover, evaluated during the 6
-hydroxydopamine-induced upregulation (7-19 days after the completion
of treatment with 6-hydroxydopamine) revealed an increase in the half-
life of the alpha(1)-adrenoceptor (t(1/2) of 67.2 h versus 38.7 h in c
ontrol animals). The present study confirms an increase in alpha(1)-ad
renoceptors in rat myocardium after chemical denervation and reveals t
hat the effect is almost completely confined to the alpha(1A)-adrenoce
ptor subtype. Furthermore, the up-regulation of alpha(1A)-adrenoceptor
s is the result of a decrease in the cellular processes that control t
he rate of receptor degradation.